Fresh Start Private Management, Inc. Executes Letter of Intent to Sell Licensing Rights to Connecticut
LOS ANGELES, CA--(Marketwired - Nov 7, 2013) - Fresh Start Private Management Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announced it has entered into a letter of intent to sell the exclusive license and distribution rights of its alcohol treatment program to JPL, LLC. Under the terms of the pending agreement, JPL, LLC will agree to pay Fresh Start Private an upfront licensing fee and running royalties on all program sales in the state of Connecticut.
The population of Connecticut is approximately 3.9 million people and many families there suffer from the effects of alcoholism. This pending agreement creates the potential to help countless people suffering from this deadly disease in that region of the country, and it would create an entirely new revenue stream for Fresh Start Private Management, Inc.
"We are very excited about this pending relationship with JPL. The reason why this agreement is so important, aside from the immediate cash infusion from the up-front license fee and then the running royalties, is that it would give us a presence in the massively populated Northeastern region of the US. Our goal is to help more people and this agreement would be another step forward to accomplishing that goal. There are tens of millions of people in the Northeastern region," said Kent Emry, CEO of Fresh Start Private Management, Inc. "We look forward to further developing that region as we continue to expand across the country."
About Fresh Start Private
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, please visit www.freshstartprivate.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.